This week, Don’s not holding back with what he thinks about this penny stock…

Last week, Executive Director Don Yocham tackled an important question that we’ve been hearing a lot lately – it seems that our members aren’t sure what to make of Aurora Cannabis Inc. (NYSE: ACB).

While Aurora has never been in any of our model portfolios, we know that a lot of our members do own the stock.

Well, Don believes that Aurora has way too much capital invested and that it will not be able to generate a positive return. But that’s only the tip of the iceberg.

He’s not sure if the company will ever right the ship and, for Cannabis Investor’s Report members, he gives an in-depth analysis of the biggest reasons that Aurora is in trouble.

Find out how you can access this members-only report, along with hundreds of others, here.

Now, let’s jump right into the questions Don is answering this week.

One of our members wants to know more about a specific penny stock that a lot of you may be wondering about.

And after watching Don’s video, you’ll see why he wouldn’t touch it with a 10-foot pole…

Why You Need to Avoid This Penny Stock

In this edition of our Q&A session, Don answers questions about:

  • Terra Tech Corp. (OTC: TRTC)
  • Legalization in Wisconsin
  • Hexo Corp. (NYSE: HEXO)

He also talks about the NICI indices, which offer some of the best free tools available to track cannabis stocks.

And when it comes to a certain penny stock that’s been receiving a lot of attention, Don couldn’t hold back.

“I have a hard time considering this an industry leader,” and that was the least of his concerns.

Find out what stock he’s talking about and hear how he answers your other questions in the video below.

Editor’s Note: Let Don know what you’d like to know more about in the comment section of this article and you may see your question featured in the next Q&A video report!

Take care,

P.S. Don talks about two companies in his Q&A video session that are rated as 1 in our proprietary NICILytics database, which means they’re either a complete scam or simply such a bad prospect that investors should steer clear. Don’t get left in the dark anymore! As a Cannabis Investor’s Report member, you too could have full access to this database of over 200 cannabis companies where you can know at a glance which companies are worth your money. To see how you can potentially discover your next double-, triple-, or quadruple-digit winner today, go here now.


Comments

18 responses to “This Will Always Be a Penny Stock”

  1. Hi, I own some shares in IVITF (Invictus) and know that the CEO had some health issues, but is back. Does it look like they can right the ship?

  2. I’m hoping you’ll comment on EVIO. This is a real company with analytical ability in various fields including what looked like essential marijuana testing, and seemed like it was heading up early last year. What happened to make it tank and stay mired at the bottom?

  3. I’m very happy to be a part of NICI and this most exciting and growing industry of cannabis products. Thanks for the opportunity.

  4. Will the current portfolio stocks we have be reevaluated, not as far as ratings but as good buys for current conditions?

  5. hi Don, what are your thoughts on Evio labs (EVIO), Isracann Biosciences (ISCNF), and Medicine Man (MDCL)? Keep up the great work, love the Q & A.

  6. Hi,
    I bought MJAR last year and I have averaged down several times as it dropped from 4$ to 1$. It is currently worth 0.20 cents. The company has multiple operations in both canada and the US. Do you think it is a buy?

  7. Sometime I would like you to cover a formula for averaging down a share price buy in if there is a specific formula. Maybe you could start something new where portfolio share prices are being monitored so that you can let members know when a good time would be to average down on a specific company. Most of us do not know how to read a chart but I’m assuming that many of your employees do. If you kept track, you would be able to let us know at what point you think a particular company might be finding its share price bottom and therefore a good time to average down. I would also like you to cover the basic life of a stock from IPO to success or failure. Also, how about covering the best way to tell if the gains of a share price are real or just fleeting hype. You know, the original membership said that we would be given educational tools for charting and I have yet to see anything about that. It sure would be nice if you guys would teach us some things about basic chart reading.

  8. The reason that I am pushing so much for you guys to help us average down is because most of us bought into these companies last year when the share prices were much higher, especially Canopy so I think it would only be fitting for you to give us the most efficient ways to average down as close as possible to the current prices.

  9. Hi, Don. My questions: 1. What do you think of GTBIF, KSHB, and OGI? 2. Are these stocks are a buy more shares or hold status?
    Thanks in advance in replying to my questions.

  10. I have a question for the next answer session. Is Isracann Biosciences a good prospect for success in the medical cannabis field?

  11. So happy I am a member of NICI. Enjoy your newsletters and reports.
    Will keep my “eyes” open for reviews of pot stock.

  12. I am not on Facebook… not sure what happened to Don’s weekly responses on Thursday via email, so, did that go away. My question is on CNBX where the Israeli group has had success treating human cancer cells. Is that actually true or am I missing something?

Leave a Reply

Your email address will not be published. Required fields are marked *